CESANA, EUGENIO
CESANA, EUGENIO
DIPARTIMENTO DI SCIENZE CHIRURGICHE, RICOSTRUTTIVE E DIAGNOSTICHE (attivo dal 01/01/2009 al 27/04/2012)
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G : a possible role in the resistance to HIV of HIV-exposed seronegative individuals
2007-01-01 M. Biasin, L. Piacentini, S. Lo Caputo, Y. Kanari, G. Magri, D. Trabattoni, V. Naddeo, L. Lopalco, A. Clivio, E. Cesana, F. Fasano, C. Bergamaschi, F. Mazzotta, M. Miyazawa, M. Clerici
Cardiac precursors in human bone marrow and cord blood: in vitro cell cardiogenesis
2004-01-01 P. Vanelli, S. Beltrami, E. Cesana, D. Cicero, A. Zaza, E. Rossi, F. Cicirata, C. Antona, A. Clivio
Current paradigms in immunology
2006-03-11 E. Cesana, S. Beltrami, A.E. Laface, A. Urthaler, A. Folci, A. Clivio
In vitro efficacy of a non-conventional (folding) HIV-1 protease inhibitor without selection of resistance
2009-05-01 S. Ferramosca, M. Lo Cicero, A.E. Laface, F. Sirianni, E. Cesana, D. Provasi, G. Tiana, M. Galli, M. Moroni, A. Clivio, R.A. Broglia, S. Rusconi
Susceptibility to a non-conventional (folding) protease inhibitor of human immunodeficiency virus type 1 isolates in vitro
2007-01-01 S. Rusconi, M. Lo Cicero, S. Ferramosca, S. Sirianni, M. Galli, M. Moroni, A.E. Laface, E. Cesana, A. Clivio, G. Tiana, D. Provasi, R.A. Broglia
The non-conventional (folding) protease inhibitor blocks the human immunodeficiency virus type-1 replication without evidence of resistance during in vitro passage
2008-01-01 S. Ferramosca, M. Lo Cicero, A.E. Laface, F. Sirianni, E. Cesana, D. Provasi, G. Tiana, M. Galli, M. Moroni, A. Clivio, R.A. Broglia, S. Rusconi